Methylphenidate Extended-Release Capsules (Evening Formulation) and Vivaglobin
Determining the interaction of Methylphenidate Extended-Release Capsules (Evening Formulation) and Vivaglobin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: immune globulin subcutaneous
Brand name: Vivaglobin, Cutaquig, Cuvitru, Hizentra, Xembify
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Vivarin
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Vivelle
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Vivelle 100 Mcg Transdermal
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Vivelle 25 Mcg Transdermal
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Vivelle 37.5 Mcg
- Methylphenidate Extended-Release Capsules (Evening Formulation)-Vivelle Transdermal
- Vivaglobin-Methylphenidate Extended-Release Chewable Tablets
- Vivaglobin-Methylphenidate Extended-Release Oral Suspension
- Vivaglobin-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Vivaglobin-Methylphenidate Extended-Release Tablets
- Vivaglobin-Methylphenidate Hydrochloride
- Vivaglobin-Methylphenidate LA Capsules